Pharmaceutical

Filter

Current filters:

None

Popular Filters

6801 to 6825 of 6997 results

AstraZeneca in patent settlement deal with Handa over Seroquel XR

30-09-2011

Anglo-Swedish drug major AstraZeneca (LSE: AN) yesterday revealed that it has entered into a settlement…

AstraZenecaGenericsHanda PharmaceuticalsNeurologicalNorth AmericaPatentsPharmaceuticalSeroquel XR

Lundbeck partners with Proximagen, buying around a 9%equity stake in the firm

30-09-2011

Danish central nervous system specialist Lundbeck (LUND: DC) and the UK’s Proximagen Group (AIM:…

LundbeckMergers & AcquisitionsNeurologicalPharmaceuticalProximagenResearch

Pfizer partners with USA’s NABP to warn about counterfeit Rx drugs

29-09-2011

Global drugs behemoth Pfizer (NYSE: PFE) and the USA’s National Association of Boards of Pharmacy…

Markets & MarketingNorth AmericaPfizerPharmaceutical

Astellas drops development of blood thinner darexaban

29-09-2011

Japanese drug major Astellas Pharma (TYO: 4503) says it has decided to discontinue the global development…

Astellas PharmaCardio-vasculardarexabanPharmaceuticalRegulationResearch

Takeda and Pronova file for triglyceride lowererTAK-085 approval in Japan

29-09-2011

Norway-based lipid therapies specialist Pronova BioPharma says that its partner, Takeda Pharmaceutical…

Asia-PacificCardio-vascularPharmaceuticalRegulationTakeda Pharmaceuticals

Novel disease-modifying therapies will drive MS market to $11.5 billion in 2015

29-09-2011

The launch of several premium-priced novel disease-modifying therapies, including four oral agents, will…

BiotechnologyGlobalMarkets & MarketingNeurologicalPharmaceutical

Cost benefit analysis of cervical cancer vaccines sees Gardasil beat Cervarix

29-09-2011

An analysis of cervical-cancer vaccine has shown that Merck & Co’s (NYSE: MRK) Gardasil (human papillomavirus…

CervarixEuropeGardasilGlaxoSmithKlineMerck & CoPharmaceuticalPricingVaccines

Onyx Pharma files NDA for multiple myeloma drug carfilzomib

29-09-2011

California, USA-based Onyx Pharmaceuticals (Nasdaq: ONXX) says it has completed the New Drug Application…

carfilzomibNorth AmericaOncologyOnyx PharmaceuticalsPharmaceuticalRegulation

GAVI Alliance delivers on its promise to tackle diarrhea and pneumonia

29-09-2011

The GAVI Alliance announced this week that it will provide funding for 16 more developing countries to…

GlobalHealthcarePharmaceuticalVaccines

Executive appointments at Merck & Co, Actelion and Jazz Pharma

28-09-2011

US drug giant Merck & Co (NYSE: MRK) has appointed Cuong Viet Do as chief strategy officer, effective…

ActelionBiotechnologyJazz PharmaceuticalsManagementMerck & CoPharmaceutical

Canada’s national health spending crunch the result of public insurance programs, not drug costs

28-09-2011

Claims that prescription drug costs are at the root of Canada’s health spending crisis are unfounded…

HealthcareNorth AmericaPharmaceuticalPricing

MVA-B Spanish HIV vaccine shows 90% immune response in humans

28-09-2011

Phase I clinical trials developed by Spanish Superior Scientific Research Council (CSIC) together with…

Anti-viralsPharmaceuticalResearch

Off-label use of antipsychotics for some conditions not supported by evidence, says US govt agency

28-09-2011

There is little evidence to support the use of atypical antipsychotic drugs for some treatments other…

NeurologicalNorth AmericaPharmaceuticalRegulation

Psoriasis drug market set to see strong growth until 2018, reaching a value of $6.7 million

28-09-2011

The psoriasis therapeutics market is forecast to show high growth until 2018 and market research firm…

DermatologicalsGlobalImmunologicalsMarkets & MarketingPharmaceutical

GPhA joins in US drug shortages challenge, urging “unprecedented multi-stakeholder collaboration”

28-09-2011

With shortages of prescription drugs continuing in the USA, the country’s Generic Pharmaceutical…

GenericsMarkets & MarketingNorth AmericaPharmaceuticalRegulation

Novo Nordisk files for EU approval of ultra-long-acting insulins Degludec and DegludecPlus

28-09-2011

Danish insulin giant Novo Nordisk NVO: N) has made the first regulatory approval submissions, to the…

DegludecDiabetesEuropeNovo NordiskPharmaceuticalRegulation

Lilly’s Alimta shows benefit in hard-to-treat lung cancer patients

28-09-2011

US drug major Eli Lilly (NYSE: LLY) says that a new subgroup analysis of data from the pivotal Phase…

AlimtaEli LillyOncologyPharmaceuticalResearch

Ipsen enters deal with Photocure to commercialize Hexvix

28-09-2011

French drugmaker Ipsen (Euronext: IPN) has entered into a partnership with Norway-based Photocure (OSE:…

HexvixIpsenLicensingOncologyPharmaceuticalPhotocure

Mesoblast and Lonza establish strategic global manufacturing alliance for stem cell products

28-09-2011

Australian regenerative medicine company Mesoblast (ASX: MSB) and Switzerland-based Lonza Group (SWS:…

BiotechnologyLicensingLonzaMesoblastPharmaceutical

US FDA communicates concern about drospirenone-containing birth control pills

27-09-2011

The US Food and Drug Administration (FDA) is informing the public that it has not yet reached a conclusion,…

BayerDrospirenone and Ethinyl EstradiolNorth AmericaPharmaceuticalRegulationReproductiveYasminYaz

6801 to 6825 of 6997 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top